Skip to main content
. 2023 May 23;19(8):637–644. doi: 10.1200/OP.22.00738

FIG 1.

FIG 1.

(A) Outcomes of genetics services consults among all patients with an active consult during the study period. (B) Outcomes of genetics services consults among all patients with cancer. Outcomes of all genetics services consults among all (C) SIRE-Black and (D) SIRE-White patients. (E) Flowchart depicting the analysis of predictors of germline testing completion. GT, germline testing; Pref, preferred; PV, pathogenic variant; Rec, recommended; SIRE, self-identified race/ethnicity; VUS, variant of uncertain significance.